Why is RLAY Up Today?

RLAY
$18.62
▲ +3.16% (+$0.59)
Last updated: Oct 01, 2026 8:35 PM ET (213 min ago)

About Relay Therapeutics, Inc. Common Stock

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge c...

Sector: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Cap: $917.23M
Forward P/E: -4.0
52-Week Range: $5.17 - $21.27
Employees: 197

Overall Confidence: 60%

60% Confident

Based on news, social sentiment, options activity, and sector analysis

SYMPATHY 60% Confidence
🎯 Outperforming sector by 4.8%
This stock is significantly outperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.

✅ Move Confirmation

LOW VOLUME 0.5x average volume

UNCONFIRMED - Low volume suggests this move may not be sustainable.

📍 Sector Context

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: -1.7%

RLAY is outperforming its sector by 4.8%. This suggests a stock-specific catalyst.

Market Comparison

RLAY is significantly outperforming the market (+3.0% vs SPY)
S&P 500
SPY
+0.18%
Nasdaq 100
QQQ
+0.31%
RLAY
This Stock
+3.16%
vs S&P 500: +2.98%
vs Nasdaq: +2.85%

📊 What Happens Next?

Probability Analysis

45% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, RLAY is expected to trade between:
$18.25 - $19.18

Key Level to Watch

$19.55 resistance
Watch for continuation above $18.62

🔔 Get RLAY Alerts

We'll notify you when RLAY's trend changes or a new signal fires.

Last updated: Oct 01, 2026 8:35 PM (213 minutes ago)
Data refreshes every 30 minutes during market hours

Options Market Insight

Neutral
Options Sentiment
1.16
Put/Call Ratio
149.9%
Implied Volatility
Call Volume: 9,049
Put Volume: 10,532
Total: 19,581

Historical Context

RLAY has moved more than 3.0% up on 57 occasions in the past year.

49.1%
Continuation Rate
28/57 times continued up
+0.67%
Avg Next Day Change
After similar up moves
Last similar move: Sep 29, 2026 (3.8%) → Next day: -1.7%

Frequently Asked Questions

Why is RLAY stock up today?

This stock is significantly outperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.

Is RLAY stock a buy or sell right now?

Based on current analysis, RLAY shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →

What is the RLAY stock price target?

RLAY is currently trading at $18.62. Based on today's momentum, the expected short-term range is $18.25 - $19.18. See long-term price prediction →

Will RLAY stock continue rising?

Our analysis shows a 45% probability that RLAY's move continues in the next 1-3 days. Key level to watch: $19.55 (resistance).

Is RLAY stock oversold or overbought?

RLAY's RSI (Relative Strength Index) is currently at 48.6. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.

What is the momentum for RLAY stock?

RLAY's 10-day momentum indicator is at -0.7. Negative momentum - the stock has mild downward pressure which may continue short-term.

Is RLAY outperforming or underperforming the market?

RLAY (+3.16%) is currently significantly outperforming the market (+3.0% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.

What does MACD indicate for RLAY?

RLAY's MACD (-0.31) is currently below the signal line (-0.3), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 17.9) is weak.

Is RLAY in an uptrend or downtrend?

Based on moving average analysis, RLAY is in a bearish trend. The price ($18.62) is trading below both the 20-day SMA ($18.59) and 50-day SMA ($19.1). This alignment typically indicates sustained downward pressure.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL